Abstracts

Greater Early CD4 Responses to CART Initiation Not Maintained for Non-perinatal Youth

Background: Non-perinatally HIV (nPHIV)-infected youth are more likely to have delayed initiation of combination antiretroviral therapy (cART) and have higher nonadherence to cART than adults. Youth have residual thymic tissue and potentially greater capacity for immune reconstitution than adults. We compared CD4 responses to cART between nPHIV-infected youth (12-24 years-old) and adults (≥25-44 years-old). Methodology:…

Factors Associated With Successful Retention Among Non-perinatally HIV-Infected Youth

Background: The incidence of HIV infection continues to increase among youth infected through risk behaviors, who often face individual and structural barriers to retention in care. Retention is critical for HIV treatment success, and is associated with positive clinical outcomes and a decrease in HIV transmission risk behaviors. We evaluated the clinical and demographic characteristics…

Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir

Background: Recent reports suggest that early treatment intervention during primary HIV infection has a profound impact on the viral reservoir. Indeed, the case of the Mississippi baby and the VISCONTI cohort suggests that reservoirs established early during acute HIV replication may be quantitatively and qualitatively different from reservoirs established later in chronic infection and perhaps…

CD4 T-cell Subset Composition of HIV Reservoirs in Gut Lymphnode and Blood During HAART

Background: Central and transitional memory CD4 Tcell maturation subsets comprise the largest fraction of the HIV reservoir in peripheral blood but less is known about the cellular composition of HIV reservoirs in those lymphoid tissues that disproportionately harbor HIV during suppressive ART. Methodology: 8 subjects on ART (5 started treatment during chronic infection, 3 during…

Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence

Background: Understanding the mechanisms of HIV persistence during ART is important for developing curative strategies. Our previous work suggests that proliferation of HIV-infected cells helps sustain the HIV DNA reservoir during ART. To confirm that HIV-infected cells proliferate and investigate how specific HIV-infected cells persist during suppressive ART, viral integration sites and the associated envelope…

Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo

Background: HIV-1 persists in a latent reservoir (LR) despite antiretroviral therapy (ART). This reservoir is the major barrier to HIV-1 eradication. Current approaches to purge the LR involve pharmacologic induction of HIV-1 transcription and subsequent killing of infected cells by cytolytic T lymphocytes or viral cytopathic effects. Agents that reverse latency without activating T cells…

Effect of Vorinostat on Host Gene Expression in HIV- Infected Patients on Antiretroviral Therapy

Background: Histone deacetylase inhibitors (HDACi) activate HIV production in latently infected T-cells in vitro. Recently, the HDACi vorinostat was shown to significantly increase cell associated unspliced (CA-US) HIV RNA in HIV infected subjects on suppressive antiretroviral therapy (ART). However, the effects of vorinostat on host gene regulation and the relationship of these changes to efficacy…

Cyclophosphamide Enhances SB-728-T Engraftment to Levels Associated with HIV-RNA Control

Background: SB-728-T is a zinc finger nuclease-mediated, CCR5-modified autologous CD4 T-cell product that can provide a reservoir of CD4 T-cells that are resistant to HIV entry. Studies in ART-treated CCR5 Δ32 heterozygote HIV subjects showed VL reductions from peak during treatment interruption that correlated with estimated circulating bi-allelic CCR5-modified CD4 T-cells (maximal at ~200 cells/ul),…

Stimulation of subdominant CTL response is required for the elimination of HIV-1 latent reservoir

Background: HAART can control viral replication in HIV-1 infected individuals, but can’t eliminate the virus due to viral persistence in latent reservoirs. Eradication strategies have focused on reactivation of latent HIV-1 in the reservoir without global T cell activation. Our recent study suggested reactivation of latent HIV-1 alone might not be enough, and stimulation of…